TrialBMC complementary and alternative medicine2015

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.

Wei Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.